MURR and Curium Extend Partnership to Strengthen Supply of Critical Cancer-fighting Radioisotope
September 25, 2026
September 25, 2026
COLUMBIA, Missouri, Sept. 25 -- The University of Missouri issued the following news release:
* * *
MURR and Curium extend partnership to strengthen supply of critical cancer-fighting radioisotope
Lutetium-177 -- a radioisotope produced at the University of Missouri -- is used in precision therapies that target and destroy cancer cells.
Sept. 25, 2026
As demand grows for targeted cancer treatments, the University of Missouri Resear . . .
* * *
MURR and Curium extend partnership to strengthen supply of critical cancer-fighting radioisotope
Lutetium-177 -- a radioisotope produced at the University of Missouri -- is used in precision therapies that target and destroy cancer cells.
Sept. 25, 2026
As demand grows for targeted cancer treatments, the University of Missouri Resear . . .